Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Nature Communications|April 9, 2026
Combining multiplexed assays of variant effect for enhanced BRCA2 variant classificationChunling Hu, Sounak Sahu, Wenan Chen, et al.Clinical Breast Cancer|November 8, 2024
Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic ExperienceNusrat Jahan, Jodi Taraba, Nicholas J Boddicker, et al.Blood Cancer Journal|November 6, 2024
Mosaic chromosomal alterations (mCAs) in individuals with monoclonal B-cell lymphocytosis (MBL)Aswin Sekar, Rosalie Griffin, Sameer A Parikh, et al.Medrxiv : the Preprint Server for Health Sciences|December 25, 2025
Meta-analysis of genome-wide association studies of doxorubicin-induced arrhythmia identifies MMP16 and KCTD15 as risk lociJoseph S Reddy, Milagros Pereyra, Mohammed Tiseer Abbas, et al.Circulation. Genomic and Precision Medicine|July 29, 2026
Meta-Analysis of Genome-Wide Association Studies of Doxorubicin-Induced Arrhythmia Identifies MMP16 and KCTD15 as Risk LociJoseph S Reddy, Milagros Pereyra, Mohammed Tiseer Abbas, et al.BMC Genomics|May 29, 2015
Identification of a putative quantitative trait nucleotide in guanylate binding protein 5 for host response to PRRS virus infectionJames E Koltes, Eric Fritz-Waters, Chris J Eisley, et al.American Journal of Hematology|April 13, 2020
Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic indexGeffen Kleinstern, Daniel R O'Brien, Xing Li, et al.Blood Cancer Journal|November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.Blood Advances|March 6, 2023
Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLLRosalie Griffin, Julia E Wiedmeier-Nutor, Sameer A Parikh, et al.Journal of Hematology & Oncology|January 6, 2026
Multiple myeloma risk linked to DNA damage response genesMichael Conry, Irina Ostrovnaya, Yelena Kemel, et al.Pageof 4